Stock Analysis

Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50

The board of Biocon Limited (NSE:BIOCON) has announced that it will pay a dividend on the 5th of September, with investors receiving ₹0.50 per share. This payment means the dividend yield will be 0.1%, which is below the average for the industry.

Advertisement

Biocon's Future Dividend Projections Appear Well Covered By Earnings

While yield is important, another factor to consider about a company's dividend is whether the current payout levels are feasible. However, prior to this announcement, Biocon's dividend was comfortably covered by both cash flow and earnings. This means that most of what the business earns is being used to help it grow.

The next year is set to see EPS grow by 87.2%. If the dividend continues along recent trends, we estimate the payout ratio will be 3.1%, which is in the range that makes us comfortable with the sustainability of the dividend.

historic-dividend
NSEI:BIOCON Historic Dividend June 18th 2025

See our latest analysis for Biocon

Dividend Volatility

Although the company has a long dividend history, it has been cut at least once in the last 10 years. The annual payment during the last 10 years was ₹0.833 in 2015, and the most recent fiscal year payment was ₹0.50. Doing the maths, this is a decline of about 5.0% per year. A company that decreases its dividend over time generally isn't what we are looking for.

The Dividend Has Growth Potential

With a relatively unstable dividend, it's even more important to see if earnings per share is growing. Biocon has impressed us by growing EPS at 5.2% per year over the past five years. With a decent amount of growth and a low payout ratio, we think this bodes well for Biocon's prospects of growing its dividend payments in the future.

Our Thoughts On Biocon's Dividend

Overall, a consistent dividend is a good thing, and we think that Biocon has the ability to continue this into the future. The payout ratio looks good, but unfortunately the company's dividend track record isn't stellar. The dividend looks okay, but there have been some issues in the past, so we would be a little bit cautious.

Market movements attest to how highly valued a consistent dividend policy is compared to one which is more unpredictable. However, there are other things to consider for investors when analysing stock performance. As an example, we've identified 1 warning sign for Biocon that you should be aware of before investing. If you are a dividend investor, you might also want to look at our curated list of high yield dividend stocks.

Valuation is complex, but we're here to simplify it.

Discover if Biocon might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NSEI:BIOCON

Biocon

Manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally.

Reasonable growth potential with adequate balance sheet.

Advertisement

Updated Narratives

NI
niteco
TXN logo
niteco on Texas Instruments ·

Engineered for Stability. Positioned for Growth.

Fair Value:US$31546.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BE
Bejgal
MNSO logo
Bejgal on MINISO Group Holding ·

MINISO's fair value is projected at 26.69 with an anticipated PE ratio shift of 20x

Fair Value:US$28.1829.5% undervalued
46 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
BE
Bejgal
FVRR logo
Bejgal on Fiverr International ·

Fiverr International will transform the freelance industry with AI-powered growth

Fair Value:US$36.8143.1% undervalued
79 users have followed this narrative
7 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.4% undervalued
109 users have followed this narrative
10 users have commented on this narrative
21 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3929.3% undervalued
937 users have followed this narrative
6 users have commented on this narrative
24 users have liked this narrative
OS
oscargarcia
GOOGL logo
oscargarcia on Alphabet ·

The company that turned a verb into a global necessity and basically runs the modern internet, digital ads, smartphones, maps, and AI.

Fair Value:US$3405.8% undervalued
145 users have followed this narrative
6 users have commented on this narrative
18 users have liked this narrative